Lipodystrophy, Congenital Generalized
Also known as: Congenital generalised lipodystrophy / Congenital Generalized lipodystrophy / Total lipodystrophy / Congenital lipodystrophy / Lipodystrophy congenital / Lawrence-Seip syndrome / Congenital lipoatrophic diabetes / Acquired generalized lipodystrophy (disorder) / Berardinelli-Seip syndrome / Congenital total lipodystrophy (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09046 | Metreleptin | A leptin analogue used as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients various forms of lipodystrophy. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB09046 | Metreleptin | Leptin receptor | target |
| Drug | Drug Name | Phase | Status | Count |
|---|